bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Dec. 13, 2023
Abstract
Promiscuous
editing
by
CRISPR/Cas
systems
within
the
human
genome
is
a
major
challenge
that
must
be
addressed
prior
to
applying
these
therapeutically.
In
bacteria,
have
evolved
in
co-evolutionary
arms
race
with
infectious
phage
viruses
contain
inhibitory
anti-CRISPR
proteins
their
genomes.
Here,
we
harness
outcome
of
this
engineer
an
AcrIIA4
protein
increase
precision
CRISPR/Cas-based
targeting.
We
developed
approach
specifically
leveraged
(1)
language
models,
(2)
deep
mutational
scanning,
and
(3)
highly
parallel
DNA
repair
measurements
cells.
single
experiment,
∼10,000
variants
were
tested
identify
lead
eliminated
detectable
off-target
events
while
retaining
on-target
activity.
The
candidates
further
focused
round
screening
included
high-fidelity
version
Cas9
as
benchmark.
Finally,
arrayed
experiments
using
delivered
ribonucleoprotein
conducted
demonstrated
gene
across
two
independent
genomic
loci
reduction
frequency
translocation
between
site.
Thus,
language-model-guided
high-throughput
effective
way
efficiently
precision,
which
could
used
improve
fidelity
editing-based
therapeutics
reduce
genotoxicity.
Nature Genetics,
Journal Year:
2025,
Volume and Issue:
57(1), P. 140 - 153
Published: Jan. 1, 2025
Abstract
The
mutational
landscape
of
TP53
,
a
tumor
suppressor
mutated
in
about
half
all
cancers,
includes
over
2,000
known
missense
mutations.
To
fully
leverage
mutation
status
for
personalized
medicine,
thorough
understanding
the
functional
diversity
these
mutations
is
essential.
We
conducted
deep
scan
using
saturation
genome
editing
with
CRISPR-mediated
homology-directed
repair
to
engineer
9,225
variants
cancer
cells.
This
high-resolution
approach,
covering
94.5%
cancer-associated
mutations,
precisely
mapped
impact
individual
on
cell
fitness,
surpassing
previous
studies
distinguishing
benign
from
pathogenic
variants.
Our
results
revealed
even
subtle
loss-of-function
phenotypes
and
identified
promising
mutants
pharmacological
reactivation.
Moreover,
we
uncovered
roles
splicing
alterations
nonsense-mediated
messenger
RNA
decay
mutation-driven
dysfunction.
These
findings
underscore
power
advancing
clinical
variant
interpretation
genetic
counseling
therapy.
Biochemistry,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 18, 2025
Biased
signaling
has
transformed
pharmacology
by
revealing
that
receptors,
particularly
G
protein-coupled
receptors
(GPCRs),
can
activate
specific
intracellular
pathways
selectively
rather
than
uniformly.
This
discovery
enables
the
development
of
targeted
therapeutics
minimize
side
effects
precisely
modulating
receptor
activity.
Functionally
selective
ligands,
which
preferentially
distinct
branches,
have
become
essential
tools
for
exploring
mechanisms
and
uncovering
complexities
GPCR
signaling.
These
ligands
help
clarify
function
in
various
physiological
pathological
contexts,
offering
profound
implications
therapeutic
innovation.
GPCRs,
mediate
a
wide
range
cellular
responses
through
coupling
to
proteins
arrestins,
are
key
pharmacological
targets,
with
nearly
third
FDA-approved
drugs
acting
on
them.
Recent
advancements
biosensor
development,
multiplex
assay
platforms,
deep
mutational
scanning
methods
improving
our
ability
define
signaling,
allowing
better
understanding
biased
pathways.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: March 27, 2024
Abstract
Cone-Rod
Homeobox,
encoded
by
CRX
,
is
a
transcription
factor
(TF)
essential
for
the
terminal
differentiation
and
maintenance
of
mammalian
photoreceptors.
Structurally,
comprises
an
ordered
DNA-binding
homeodomain
intrinsically
disordered
transcriptional
effector
domain.
Although
handful
human
variants
in
have
been
shown
to
cause
several
different
degenerative
retinopathies
with
varying
cone
rod
predominance,
as
most
disease
genes
vast
majority
observed
genetic
are
uncharacterized
uncertain
significance
(VUS).
We
performed
deep
mutational
scan
(DMS)
nearly
all
possible
single
amino
acid
substitution
CRX,
using
engineered
cell-based
reporter
assay.
measured
ability
each
missense
variant
transactivate
synthetic
fluorescent
construct
pooled
fluorescence-activated
cell
sorting
assay
compared
activation
strength
that
wild-type
compute
activity
score,
identifying
thousands
altered
activity.
calculated
statistical
confidence
score
derived
from
multiple
independent
measurements
marked
unique
sequence
barcodes,
curating
high-confidence
list
2,000
significantly
CRX.
evaluated
performance
DMS
clinical
classification
tool
gold-standard
classified
ClinVar,
determined
scores
could
be
used
identify
pathogenic
high
specificity.
That
this
achieved
foreign
type,
even
highly
type-specific
TF
like
suggests
approach
shows
promise
other
TFs
function
types
not
easily
accessible.
Per-position
average
closely
aligned
predicted
structure
demonstrated
position-specific
residue
requirements.
The
domain,
contrast,
displayed
qualitatively
pattern
effects,
following
compositional
constraints
without
specific
position
requirements
peptide
chain.
domain
were
consistent
acidic
exposure
model
activation.
Together,
results
molecular
features
demonstrate
utility
classification.
British Journal of Pharmacology,
Journal Year:
2024,
Volume and Issue:
181(22), P. 4593 - 4609
Published: Aug. 2, 2024
Abstract
Background
and
Purpose
The
ATP‐dependent
biliary
efflux
transporter
ABCC2,
also
known
as
multidrug
resistance
protein
2
(MRP2),
is
essential
for
the
cellular
disposition
detoxification
of
various
xenobiotics
including
drugs
well
endogenous
metabolites.
Common
functionally
relevant
ABCC2
genetic
variants
significantly
alter
drug
responses
contribute
to
side
effects.
aim
this
study
was
determine
functional
consequences
rare
identified
in
subjects
with
European
ancestry
using
silico
tools
vitro
analyses.
Experimental
Approach
Targeted
next‐generation
sequencing
gene
used
identify
novel
(n
=
143).
Twenty‐six
were
predict
consequences.
For
biological
validation,
transport
assays
carried
out
membrane
vesicles
prepared
from
cell
lines
overexpressing
newly
estradiol
β‐glucuronide
carboxydichlorofluorescein
substrates.
Key
Results
Three
missense
(W227R,
K402T,
V489F).
Twenty‐five
predicted
W227R
damaging
one
potentially
damaging.
Prediction
not
possible
K402T
V489F
common
linked
V1188E/C1515Y.
Characterisation
showed
increased
function
W227R,
V1188E/C1515Y
both
substrates,
whereas
only
carboxydichlorofluorescein.
Conclusion
Implications
In
unable
accurately
substrate‐dependent
increase
variants.
studies
are
required
activity
avoid
misleading
therapy.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 3, 2024
Abstract
The
rapid
emergence
of
drug
resistance
in
malaria
parasites
poses
a
significant
challenge
to
the
efficacy
antifolate
treatments.
Traditional
development
approaches,
which
often
rely
on
empirical
screening
with
limited
mechanistic
insights,
tend
overlook
complex
evolutionary
mechanisms
that
enable
Plasmodium
falciparum
evade
inhibition
while
preserving
enzyme
functionality.
In
this
study,
we
employed
computational
techniques
investigate
mutational
landscape
dihydrofolate
reductase
(DHFR),
focusing
regions
essential
for
stability
and
resistance.
Our
analysis
uncovered
conserved
residues
stability,
mutation
hotspots
enhance
adaptability
under
pressure
co-evolving
clusters
revealing
critical
functional
interdependencies.
Through
integrated
approaches
including
scanning,
epistatic
interaction
modeling,
fitness
trajectory
mapping,
elucidated
distinct
pathways
drive
We
were
able
track
adaptive
paths
taken
by
wild-type
upon
mutation,
steps
required
reach
high-fitness
peaks
within
rugged
landscape.
These
findings
provide
valuable
insights
into
molecular
suggest
future
design
should
target
networks
support
next-generation
therapies
overcome